Explore the words cloud of the BEEOXAL project. It provides you a very rough idea of what is the project "BEEOXAL" about.
The following table provides information about the project.
SAGAVET SOLUCIONES S.L.
|Coordinator Country||Spain [ES]|
|Total cost||71˙429 €|
|EC max contribution||50˙000 € (70%)|
1. H2020-EU.3.5. (SOCIETAL CHALLENGES - Climate action, Environment, Resource Efficiency and Raw Materials)
2. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
|Duration (year-month-day)||from 2017-08-01 to 2017-11-30|
Take a look of project's partnership.
|1||SAGAVET SOLUCIONES S.L.||ES (MATARO BARCELONA)||coordinator||50˙000.00|
Varroosis is the most serious honeybee disease worldwide, causing €197 million loss yearly in the eight main European beekeeping countries, and severe population decline of this main pollination agent, with strong impact on agriculture and wildlife biodiversity. Negative effects are of such extent that the EU provides specific funding (€33.1 M, 2014-16), to support beekeepers applying compulsory annual anti-varroosis treatments, but current medicaments cannot effectively control varroosis because none, either synthetic of organic, guarantee all the features required for optimal pest control: 1) High efficacy; 2) natural and safe for humans, honeybees and environment; 3) no resistance development; 4) Easy-to-use. BEEOXAL outmatches existing solutions by combining these four features. It consists of a treatment kit with (1) easy-to-use mono-dose pellets and (2) a specifically developed device that burns (sublimates) the tablet so it is spread like a cloud inside the hive. BEEOXAL results from the research and vast field experience of Sagavet Soluciones SL, a Spanish SME delivering animal health solutions. Based on a component already present in honey, oxalic acid, BEEOXAL has an efficacy of 96.8%, a large therapeutic margin thanks to improved spot-on formulation and dosage. Unlike synthetic products, BEEOXAL’s organic nature ensures no residue. The ready-for-use mono-dose pellets do not require mixing or handling, and the burner device to directly sublimate the tablet inside each hive allows a homogeneous distribution of the medicament in 30 seconds (x6 times faster than current treatments). This is crucial since it allows beekeepers to work safely and to avoid under/over doses (secure), maximising overall effectiveness. Backed by its international network (Cenavisa, Byopic), Soluciones Apícolas forecasts €6.8 million cumulative revenue for 2020-2022, and payback of 1 year, while generating 12 new jobs.
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BEEOXAL" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (firstname.lastname@example.org) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "BEEOXAL" are provided by the European Opendata Portal: CORDIS opendata.
The most effective and economically attractive solution for treating oily waste water on vessels and keeping our oceans cleanerRead More
Paired Electrochemical Oxidation process for feasible industrial production of the crucial FDCA building block for the bioplastic industryRead More
A Novel Technology to Reduce Industrial Dust Pollution and to Enable Most Efficient Energy RecoveryRead More